Rutgers Secures US FDA Emergency Use Authorization for New Coronavirus Saliva Test
A new collection approach that utilizes saliva as the primary test biomaterial for the SARS-CoV-2 coronavirus has become the first such method to be granted Emergency Use Authorization (EUA) by the Food and Drug Administration (FDA). More...20 Apr 2020
COVID-19: 155 Drugs and 79 Vaccines Currently Under Development Worldwide
A total of 155 drugs and 79 vaccines are currently being developed worldwide to combat COVID-19, according to a study released by the Austrian Institute for Health Technology Assessment (AIHTA; Vienna, Austria), based on figures compiled in collaboration with the organization's European counterparts. More...20 Apr 2020
RT-LAMP Assay Developed for SARS-CoV-2
SARS-CoV-2 is the causative viral pathogen of COVID-19, and diagnosis of COVID-19 can be done through CT scan of suspicious patients and a confirmatory laboratory test is performed using published real-time quantitative polymerase chain reaction (RT-qPCR) methods. More...20 Apr 2020
Sense Accelerates World’s First Instrument-Free, POC Molecular Diagnostic Test for COVID-19
Sense Biodetection Limited (Oxford, UK) has accelerated its program to launch the world’s first instrument-free, point-of-care molecular diagnostic test for SARS-CoV-2, the coronavirus responsible for the COVID-19 pandemic. More...18 Apr 2020
Rapid, Bluetooth-Connected Test Diagnoses COVID-19 in 60 Seconds
Hememics Biotechnologies Inc. (Gaithersburg, MD, USA) is partnering with the Biomedical Advanced Research and Development Authority {(BARDA) Washington, DC, USA}, a division of the Office of the Assistant Secretary for Preparedness and Response (ASPR) within the US Department of Health and Human Services (HHS), on the development of a rapid, Bluetooth®-connected, easy-to-use test to diagnose COVID-19 in 60 seconds or less. More...18 Apr 2020
Gold Member
C-Reactive Protein Reagent
CRP Ultra Wide Range Reagent Kit
New
Silver Member
Benchtop Image Acquisition Device
Microwell Imager
New
Vibrio Cholerae O1/O139 Rapid Test
StrongStep Vibrio Cholerae O1/O139 Antigen Combo Rapid Test
In Other News
Roche Launches New COVID-19 Antibody Test System
DiaCarta’s QuantiVirus PCR Diagnostic Test Receives US FDA Emergency Use Authorization
Thermo Fisher and Ford Partner to Scale Production of Collection Kits for COVID-19 Tests
DiaSorin to Launch New LIAISON IgG Test for Detecting Immune Response to SARS-CoV-2
Eurofins Launches Range of ELISA Testing Kits for COVID-19 Antibody Detection
72nd AACC Annual Scientific Meeting & Clinical Lab Expo Rescheduled to December 13-17, 2020 Due to COVID-19
New Rapid Testing Method That Detects Viral Antigens Can Diagnose COVID-19 at Early Stage
BD Announces Second FDA Emergency Use Authorization for New COVID-19 Molecular Diagnostic Test
Abbott’s Third COVID-19 Test Launched, Begins Shipping in US
Ortho's Total Antibody Test for COVID-19 Secures FDA Emergency Use Authorization
First Ever Multiplexed Serological SARS-CoV-2 Assay Released for Use in Surveillance Studies
New Coronavirus Test Works 10 Times Faster
SARS-CoV-2 Found in Sputum/Feces After Negative Pharyngeal Specimens
College of American Pathologists Releases New Proficiency Testing Program for Detection of SARS CoV-2
PHASE Scientific Launches RNA Extraction Kit for COVID-19 Test
PCR Biosystems Ramps Up Production of Critical Enzyme Mix for COVID-19 Tests
Co-Diagnostics Receives FDA EUA for Logix Smart Coronavirus COVID-19 Test
Bio-Rad Launches Serology Assay for Detection of Coronavirus Antibodies
Canon Medical Developing Rapid Genetic Testing System for Novel Coronavirus
Rapid, Portable, Point-of-Care COVID-19 Test Receives USD 13 Million Funding from BARDA
Thermo Fisher Launches New AcroMetrix Coronavirus 2019 (COVID-19) RNA Control
New Coronavirus (COVID-19) Antibody Test Can Help Determine Past COVID Infection
Fluxergy Submits FDA EUA Request for One-Hour COVID-19 POC Test
